Search RDGL
Vivos Inc.
OTC Markets OTCQB · CIK 1449349
Last close0.05
Daily change-0.00 (-8.05%)
10 Years gain-97.09%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
RDGL · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
53.1Momentum
100.0Acceleration
100.0Confidence
74.0Annual Revenue15
Quarterly Revenue42
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.1 / 25
Quality10.9 / 25
Capital Efficiency1.5 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 2947.9921 percentage points.
ROIC expansionROIC improved by 78.6463 percentage points.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 50.506 percentage points.
Heavy share dilution · HIGHDiluted share count increased 9.4737%.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM79.6%OK
Revenue CAGR 3Y23.28%OK
Gross Margin-64.14%OK
Operating Margin-2,692.67%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-63.97%OK
Incremental Operating Margin 3Y-1,246.05%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y9.47%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $68,379.00 | -$59,755.00 | -$3.17M | -$2.06M | -$2.16M | -87.39% | -4,628.68% | -3,160.22% | -313.42% | 452.72M |
| 2025 FY Dec 31, 2024 | $27,995.00 | -$2,984.00 | -$2.60M | -$1.68M | n/a | -10.66% | -9,303.03% | n/a | n/a | 409.67M |
| 2024 FY Dec 31, 2023 | $19,500.00 | -$6,036.00 | -$2.79M | -$1.29M | n/a | -30.95% | -14,323.83% | n/a | n/a | 368.81M |
| 2023 FY Dec 31, 2022 | $36,499.00 | $7,720.00 | -$2.52M | -$1.12M | n/a | 21.15% | -6,898.13% | n/a | n/a | 351.43M |
| 2022 FY Dec 31, 2021 | $14,887.00 | $2,887.00 | -$2.50M | -$963,819.00 | n/a | 19.39% | -16,805.25% | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $89,347.00 | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-037380, 0001493152-25-021619 |
| Revenue Growth TTM | 79.6% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-037380, 0001493152-25-021619 |
| Revenue CAGR 3Y | 23.28% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-013701 |
| Revenue CAGR 5Y | 57.75% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001493152-26-013701 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001493152-26-013701 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-037380, 0001493152-25-021619 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | -64.14% | Gross Profit / Revenue | OK | 0001493152-26-037380, 0001493152-25-021619 |
| Operating Margin | -2,692.67% | Operating Income / Revenue | OK | 0001493152-26-037380, 0001493152-25-021619 |
| ROIC | -63.97% | NOPAT / Average Invested Capital | OK | 0001493152-26-037380, 0001493152-25-021619 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | derived |
| Current Ratio | 48.85x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $0.00 | Revenue / Diluted Shares | OK | 0001493152-26-037380, 0001493152-25-021619 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |